Women's Health News

RSS

California's EWC program: Cuts alarm breast cancer survivors and advocates

Breast cancer survivors and advocates from all seven California Affiliates of Susan G. Komen for the Cure® signaled their alarm today at the recently announced cuts to California's Every Woman Counts program, which would effectively shut the doors to breast cancer screening services for 1.2 million low-income and uninsured women for the first six months of 2010.

11 Dec 2009

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Chemotherapy generally improves survival in postmenopausal breast cancer patients, according to a landmark study led by Dr. Kathy Albain of Loyola University Health System.

11 Dec 2009

Positive results from Genomic Health's Oncotype DX study in breast cancer patients with node-positive disease

Genomic Health, Inc. today announced that The Lancet Oncology published positive results from a study of Oncotype DX(®) in postmenopausal women with node-positive, estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group (SWOG), a National Cancer Institute-supported clinical trials cooperative group.

11 Dec 2009

Women with high BMI are at increased risk of dying from breast cancer

Breast cancer patients with a high body mass index (BMI) have a poorer cancer prognosis later in life. Specifically, their treatment effect does not last as long and their risk of death increases.

11 Dec 2009

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

AstraZeneca (NYSE: AZN) today announced that data from a Phase III study of postmenopausal women with hormone receptor-positive advanced breast cancer presented at the San Antonio Breast Cancer Symposium (Abstract 25) showed treatment with fulvestrant (FASLODEX) 500 mg reduced the risk of disease progression (assessed as time to progression (TTP)) by 20%

11 Dec 2009

Soyfood consumption linked to decreased risk of breast cancer, finds study

A major new study published in the Journal of the American Medical Association (JAMA) finds that women with breast cancer would be well-served by including soyfoods in their daily diet. Soyfood consumption was significantly linked to a decreased risk of death and cancer recurrence among the breast cancer patients in this study.

11 Dec 2009

Moderate consumption of alcoholic beverages increases the risk of breast cancer recurrence

Moderate consumption of alcoholic beverages (at least three to four drinks per week, no matter the type of alcohol) is associated with a 30 percent increased risk of breast cancer recurrence, according to a new Kaiser Permanente study. Post-menopausal or overweight women may be most susceptible to the effects of alcohol on recurrence, according to the researchers.

10 Dec 2009

YM BioSciences announces results of collaborative antibody development program

YM BioSciences Inc., today announced the first results of a collaborative program between YM and the National Research Council of Canada's Biotechnology Research Institute (NRC-BRI). Utilizing YM's IntelliMab(TM) technology, the program is designed to generate novel antibodies that target cell surface receptors associated with cancer, uniquely optimized to produce efficacy with reduced toxicities.

10 Dec 2009

U.S. bishops: Senate vote to table Nelson-Hatch-Casey amendment, a serious blow to genuine health care reform

"The Senate vote to table the Nelson-Hatch-Casey amendment is a grave mistake and a serious blow to genuine health care reform," said Cardinal Francis George, President of the United States Conference of Catholic Bishops.

10 Dec 2009

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from the Tulip PETAL Study (703 Study), its fifth Phase 2 clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.

10 Dec 2009

Arrayit Diagnostics signs exclusive License Agreement with Wayne State University

Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today announced that it has signed an exclusive License Agreement with Wayne State University to key intellectual property covering discoveries of biomarkers of ovarian cancer.

10 Dec 2009

Roche to present data on its Herceptin, Avastin and T-DM1 studies at CTRC-AACR Symposium

Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.

9 Dec 2009

Senate rejects abortion amendment, sparking new fight

The Hill: "The Senate voted against strengthening restrictions for federal funding of abortion Tuesday evening, a development that could imperil Democrats' efforts to pass an underlying healthcare reform bill. Sen. Ben Nelson (D-Neb.), who offered the amendment, had indicated that he could support a Republican filibuster of the healthcare reform bill if the abortion language were not added to it."

9 Dec 2009

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

Osteologix Inc. announced today that the company anticipates that it will be prepared to file a marketing application in 2011 in the European Union for its proprietary second-generation strontium therapy, NB S101 (strontium malonate). If successful, this will be Osteologix' first marketing approval of NB S101 for the treatment of postmenopausal osteoporosis.

9 Dec 2009

First Edition: December 9, 2009

Today's coverage details last night's tentative agreement struck by Senate Democratic negotiators in an effort to clear the public option impasse, and a vote on an abortion amendment.

9 Dec 2009

Insurrecta Nex: Will Catholic Bishops truly defend babies?

Beginning Wednesday, December 9, Insurrecta Nex team members will travel to 13 Cathedrals in 9 states to hold vigils and press conferences. The tour will finish at the Boston Cathedral, the seat of Cardinal O'Malley, the site of decades of scandal with the Kennedy and the Kerry families.

9 Dec 2009

March of Dimes poll finds majority of pregnant women worry about birth defects

The March of Dimes polled about 1,200 moms to find out exactly what it is that caused them to lose sleep (other than the fact they were pregnant!) while they were pregnant. The results were presented today at the March of Dimes National Communications Advisory Council luncheon where experienced, practicing obstetricians and gynecologists discussed the survey results, as well as some of the frequently asked questions their patients ask.

9 Dec 2009

FRC: Taxpayers to foot the bill for abortion-on-demand

This evening, the Nelson-Hatch abortion anti-funding amendment to the "Patient Protection and Affordable Care Act" was "tabled" by a vote of 54-45, thus killing any hope to make the health care bill abortion neutral. The Nelson-Hatch amendment would have prevented government funding for elective abortion in the public option or subsidies for health plans in the government run exchange that cover elective abortion.

9 Dec 2009

Soy food beneficial for women with breast cancer

Although there is a concern regarding the safety of soy food consumption among breast cancer survivors, researchers have found that women in China who had breast cancer and a higher intake of soy food had an associated lower risk of death and breast cancer recurrence, according to a study in the December 9 issue of JAMA.

9 Dec 2009

New article in Women's Health journal emphasizes the importance of early pregnancy detection

A new article published in the peer-reviewed journal Women's Health emphasizes the importance of early pregnancy detection. Using research conducted on behalf of Church & Dwight Co. Inc., the makers of First Response, the article reviews data that shows not all at-home pregnancy tests are created equal -First Response brand pregnancy tests are more sensitive and able to detect key variants of the pregnancy hormone better than other at home pregnancy tests.

9 Dec 2009

Women's Health News

California's EWC program: Cuts alarm breast cancer survivors and advocates

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Positive results from Genomic Health's Oncotype DX study in breast cancer patients with node-positive disease

Women with high BMI are at increased risk of dying from breast cancer

Fulvestrant 500 mg reduces risk of disease progression in women with metastatic breast cancer

Soyfood consumption linked to decreased risk of breast cancer, finds study

Moderate consumption of alcoholic beverages increases the risk of breast cancer recurrence

YM BioSciences announces results of collaborative antibody development program

U.S. bishops: Senate vote to table Nelson-Hatch-Casey amendment, a serious blow to genuine health care reform

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Arrayit Diagnostics signs exclusive License Agreement with Wayne State University

Roche to present data on its Herceptin, Avastin and T-DM1 studies at CTRC-AACR Symposium

Senate rejects abortion amendment, sparking new fight

Osteologix to file an European Marketing Application for its NB S101 strontium therapy

First Edition: December 9, 2009

Insurrecta Nex: Will Catholic Bishops truly defend babies?

March of Dimes poll finds majority of pregnant women worry about birth defects

FRC: Taxpayers to foot the bill for abortion-on-demand

Soy food beneficial for women with breast cancer

New article in Women's Health journal emphasizes the importance of early pregnancy detection

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News